HSA Registration Support Initiative for Unregistered Medical Devices

<h1>HSA Registration Support Initiative for Unregistered Medical Devices</h1> <p>The <strong>Health Sciences Authority (HSA) Registration Support Initiative</strong> helps clinically important unregistered medical devices move from Singapore's <strong>Special Access Route (SAR)</strong> toward formal registration. HSA's page was updated on <strong>26 August 2026</strong> and describes the initiative as separate from ordinary SAR applications; it addresses low-volume or low-price devices and legacy devices for which registration has been deterred by cost or dossier burden (<a href="https://www.hsa.gov.sg/medical-devices/registration-of-medical-devices/special-access-routes/registration-support-initiative-to-encourage-registration-of-unregistered-medical-devices-accessed-through-sar/">HSA, updated 26 Aug 2026</a>).</p> <h2>Why HSA introduced the initiative</h2> <p>SAR allows patient access to unregistered medical devices in exceptional circumstances, but HSA says it is not intended to be a long-term supply mechanism. The new initiative is intended to create a more sustainable supply pathway for devices that continue to meet important clinical needs in Singapore. It does not convert every SAR device into a registered device and does not remove HSA's registration assessment (<a href="https://www.hsa.gov.sg/announcements/registration-support-initiative-for-unregistered-medical-devices/">HSA, 28 August 2026</a>).</p> <p>HSA identifies the central support as a <strong>waiver of evaluation fees for eligible devices</strong>, reducing the regulatory cost of registration. The initiative is intended to help address needs in <strong>small patient populations</strong>, but it is not guaranteed registration: HSA still assesses the product through the applicable registration route. Eligibility is limited to devices meeting either of two published routes: higher-risk Class C or D devices that are essential or life-saving in rare clinical situations, non-novel, used for at least five years and supplied at low prices or quantities; or legacy devices with no registered alternatives, at least three years of local SAR clinical use through two consecutive GN-26 or GN-27 applications, and more than ten years' established use (<a href="https://www.hsa.gov.sg/medical-devices/registration-of-medical-devices/special-access-routes/registration-support-initiative-to-encourage-registration-of-unregistered-medical-devices-accessed-through-sar/">HSA, updated 26 Aug 2026</a>).</p> <h2>How clinicians and suppliers initiate support</h2> <p>Clinicians are invited to identify devices in their practice that may qualify, complete a <strong>Clinical Justification and Endorsement Form</strong>, and connect with the device supplier to initiate the process. The initiative is therefore designed around a clinical need identified in practice and a supplier willing to pursue formal registration; it is not described as a direct patient-application or household subsidy scheme (<a href="https://www.hsa.gov.sg/announcements/registration-support-initiative-for-unregistered-medical-devices/">HSA, 28 August 2026</a>).</p> <p>Public healthcare institutions obtain endorsement from their Chairman of Medical Board; private institutions and clinics use the Academy of Medicine, Singapore, which begins accepting endorsement requests from <strong>1 October 2026</strong>. Suppliers submit the endorsed clinical form with supporting evidence to HSA during the window. HSA says it will notify companies of fee-waiver eligibility by April of the following year, and eligible companies must submit the product-registration application within one year of notification (<a href="https://www.hsa.gov.sg/medical-devices/registration-of-medical-devices/special-access-routes/registration-support-initiative-to-encourage-registration-of-unregistered-medical-devices-accessed-through-sar/">HSA, updated 26 Aug 2026</a>).</p> <h2>Application windows and interpretation</h2> <p>The inaugural application window remains open until <strong>31 December 2026</strong>. After that, HSA says the initiative will open annually from <strong>1 October to 31 December</strong>. The date is an application-window schedule, not a promised approval date or a guarantee that a submitted device will be registered (<a href="https://www.hsa.gov.sg/announcements/registration-support-initiative-for-unregistered-medical-devices/">HSA, 28 August 2026</a>).</p> <p>This initiative should be kept separate from ordinary medical-device registration, SAR access, and patient financial assistance. Its published scope is regulatory support for eligible clinically important unregistered devices, with evaluation-fee relief and a clinician–supplier initiation route. The public page provides only an abstract of the initiative, so healthcare professionals and suppliers must consult the detailed HSA/MOH materials for current criteria and requirements before relying on the summary (<a href="https://www.hsa.gov.sg/announcements/registration-support-initiative-for-unregistered-medical-devices/">HSA, 28 August 2026</a>).</p> <h2>Public information and professional-access boundary</h2> <p>HSA’s public announcement labels the material as an abstract of a Dear Healthcare Professional Letter (DHCPL). It directs dentists, medical doctors and pharmacists to the Health Professionals Portal (HPP), where they can sign in with Singpass, choose their profession, open “Useful links”, and access the MOH Alert System’s “Med Device Alerts” section. This distinction matters for both applicants and retrieval: the public HSA page supports the existence, broad purpose, windows, criteria summary and application route, but it is not the complete DHCPL or a substitute for the supporting forms. A clinician or company should therefore use the detailed HSA materials and current submission instructions when determining whether a particular device satisfies every qualification condition. The initiative remains a regulatory registration-support pathway; access to the HPP or a successful submission does not itself establish a fee waiver, formal registration or permission to supply outside the applicable SAR and registration rules (<a href="https://www.hsa.gov.sg/medical-devices/registration-of-medical-devices/special-access-routes/registration-support-initiative-to-encourage-registration-of-unregistered-medical-devices-accessed-through-sar/">HSA, updated 26 August 2026</a>; <a href="https://www.hsa.gov.sg/announcements/registration-support-initiative-for-unregistered-medical-devices/">HSA DHCPL abstract, 28 August 2026</a>).</p>

简介

未注册医疗器械 HSA 注册支持计划

卫生科学局(HSA)注册支持计划旨在帮助具有临床重要性的未注册医疗器械从新加坡的特别准入途径(SAR)转向正式注册。HSA 页面于2026 年八月 26 日更新,说明该计划独立于普通 SAR 申请;该计划针对低用量或低价器械,以及因成本或申报资料负担而未能注册的传统器械(HSA,更新于 2026 年八月 26 日)。

HSA 推出该计划的原因

SAR 允许在特殊情况下让患者使用未注册医疗器械,但 HSA 表示,SAR 并非长期供货机制。该计划旨在为继续满足新加坡重要临床需求的器械建立更可持续的供应途径。它不会将所有 SAR 器械转为已注册器械,也不会免除 HSA 的注册评估(HSA,2026 年八月 28 日)。

HSA 指出的核心支持是为符合条件的器械免除评估费用,以降低注册的监管成本。该计划旨在帮助满足小规模患者群体的需求,但不保证注册:HSA 仍会按照适用的注册途径评估产品。资格仅限于符合已公布两种途径之一的器械:其一为较高风险的 C 类或 D 类器械,在罕见临床情况下属于必需或救命器械、非新颖器械、已使用至少五年,且以低价或少量供应;其二为没有已注册替代品的传统器械,已通过连续两次 GN-26 或 GN-27 申请在当地 SAR 下用于临床至少三年,且已有超过十年的成熟使用历史(HSA,更新于 2026 年八月 26 日)。

临床医生和供应商如何启动支持申请

HSA 邀请临床医生在其执业中找出可能符合条件的器械,填写临床理由与认可表格,并联系器械供应商以启动流程。因此,该计划围绕临床实践中发现的需求,以及愿意寻求正式注册的供应商而设计;它并非面向患者的直接申请或家庭补贴计划(HSA,2026 年八月 28 日)。

公立医疗机构须取得其医疗委员会主席的认可;私立机构和诊所则通过新加坡医学专科学院办理,该院从2026 年十月 1 日起开始接受认可申请。供应商须在申请期内向 HSA 提交经认可的临床表格及佐证材料。HSA 表示,将在次年四月前通知公司是否符合费用豁免资格;符合条件的公司必须在收到通知后一年内提交产品注册申请(HSA,更新于 2026 年八月 26 日)。

申请窗口与解读

首个申请窗口持续开放至2026 年十二月 31 日。此后,HSA 表示该计划将于每年十月 1 日至十二月 31 日开放。该日期是申请窗口安排,并非承诺的批准日期,也不保证已提交的器械会获注册(HSA,2026 年八月 28 日)。

该计划应与普通医疗器械注册、SAR 准入和患者经济援助区分开来。其公布的范围是为符合条件且具有临床重要性的未注册器械提供监管支持,包括减免评估费用,以及由临床医生与供应商共同启动申请的途径。公开页面仅提供该计划的摘要,因此医疗专业人员和供应商在依据此摘要行事前,必须查阅 HSA/MOH 的详细材料,了解当前标准和要求(HSA,2026 年八月 28 日)。

公开信息与专业人员访问权限界限

HSA 的公开公告注明,相关材料是《致医疗专业人员函》(DHCPL)的摘要。公告指引牙医、医生和药剂师前往医疗专业人员门户网站(HPP),使用 Singpass 登录,选择其专业,打开“有用链接”,并访问 MOH 警报系统的“医疗器械警报”部分。这一区分对申请人和信息检索都很重要:HSA 公开页面支持确认该计划的存在、大致目的、申请窗口、标准摘要和申请途径,但它并非完整的 DHCPL,也不能替代支持表格。因此,临床医生或公司在判断某一器械是否满足所有资格条件时,应使用 HSA 的详细材料和最新提交说明。该计划仍是监管注册支持途径;能够访问 HPP 或成功提交申请,本身并不意味着获得费用豁免、正式注册,或获准在适用的 SAR 和注册规则范围之外供应器械(HSA,更新于 2026 年八月 26 日;HSA DHCPL 摘要,2026 年八月 28 日)。